The financials
MiniMed Group, Inc. by the numbers
MiniMed Group, Inc. (MMED) reported revenue of $837M in Q4 2026 (quarter ended April 24, 2026), up 22% from the same quarter a year earlier. That came with a gross margin of 57% and net loss of $185M. For the full year FY2026, revenue was $3.10B (+14% year on year) and net income −$333M. Its largest product in 2026-Q1 was Continuous Glucose Monitoring Systems CGM at $390M, 49% of the disclosed total, just ahead of Consumables at 31%.
| Income statement | Q4 2026 | Q3 2025 | Change |
|---|---|---|---|
| Revenue | $837M | $687M | +22% |
| Gross profit | $480M | $395M | +22% |
| Operating income | −$93M | $21M | to a loss |
| Net income | −$185M | −$10M | n/a |
| Diluted EPS | −$0.71 | −$0.04 | n/a |
| Product | Revenue | Share |
|---|---|---|
| Continuous Glucose Monitoring Systems CGM | $390M | 49% |
| Consumables | $244M | 31% |
| Pumps | $151M | 19% |
| Product And Service Other | $5.0M | 0.6% |
Business Segments
Revenue split by product segment, from SEC XBRL filings.
Latest period: Q1 2026Total $790.0M (+15%)
Segment Latestquarter on quarteryear on year
- Continuous Glucose Monitoring Systems CGM$390.0M$390.0MQoQ +18%year on year +18%+18%+18%
- Consumables$244.0M$244.0MQoQ +15%year on year +15%+15%+15%
- Pumps$151.0M$151.0MQoQ +11%year on year +11%+11%+11%
- Product And Service Other$5.0M$5.0MQoQ -38%year on year -38%-38%-38%
Medical Instruments & Supplies
The closest names by size in the same industry